Summary & Overview
HCPCS S2230: Implantation of Magnetic Component of Semi-Implantable Hearing Device on Ossicles
HCPCS Level II code S2230 captures the surgical implantation of the magnetic component of a semi-implantable hearing device on the ossicles in the middle ear. This code is used to bill for the device implantation portion of middle-ear hearing implant procedures that restore or augment auditory function through mechanical coupling to the ossicular chain. Nationally, such procedures are important for patients with conductive or mixed hearing loss who are candidates for semi-implantable solutions when conventional hearing aids are insufficient.
Key payers in the review include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication provides a concise overview of coverage considerations across major commercial payers and Medicare, device-level billing implications, and typical sites of service (hospital operating room and ambulatory surgical center).
Readers will find benchmarking context and clinical framing: what the code represents, where the service is typically delivered, and the common modifiers associated with procedural billing for device implantation (list provided). The piece also outlines areas where payers commonly require documentation, authorization, and device-specific tracking. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code S2230 describes the implantation of the magnetic component of a semi-implantable hearing device on the ossicles in the middle ear. This procedure involves surgically placing the magnetic element of a hearing implant system that couples to the ossicular chain to transmit sound vibrations to the inner ear.
-
Service type: Surgical implantation of a hearing device component
-
Typical site of service: Hospital operating room or ambulatory surgical center
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with moderate-to-severe sensorineural or mixed conductive hearing loss who has failed conventional hearing aids or has anatomical or medical reasons favoring a semi-implantable device. The patient undergoes preoperative evaluation by an otologist or neurotologist including audiometry (pure-tone and speech testing), tympanometry, CT or MRI of the temporal bones as indicated, and multidisciplinary counseling about risks and benefits. On the day of surgery in an ambulatory surgery center or hospital operating room, under general anesthesia, the surgeon exposes the middle ear via a postauricular approach and mastoidectomy or posterior tympanotomy as needed. The magnetic component of the semi-implantable hearing device is implanted on the ossicular chain (typically on the incus or stapes head) and secured to optimize coupling and preserve ossicular mobility. Intraoperative testing (e.g., auditory brainstem response or device-specific coupling tests) confirms position and function. Postoperative care includes short outpatient observation, wound care instructions, audiologic activation and fitting after healing (typically several weeks), and scheduled follow-up with audiology and the implanting surgeon for device programming and outcome assessment. Typical sites of service are hospital outpatient departments and ambulatory surgery centers; inpatient admission is uncommon unless comorbidities require monitoring.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier (standard) |